A Phase I/II Study Of Hyper-CVAD Plus Everolimus In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia von Daver, Naval, Kantarjian, Hagop M., Thomas, Deborah A., Rytting, Michael E., Ravandi, Farhad, Jain, Nitin, Cortes, Jorge E., Garris, Rebecca, Richie, Mary Ann, Konopleva, Marina, Hu, Hongbo, Kawedia, Jitesh, Pharmd, Kirk Culotta, O'Brien, Susan, Basnett, Jordan, Xiao, Lianchun, Haung, Xuelin, Bendall, Linda J.

Volltext